1. Introduction: viral glycoprotein-induced membrane fusion {#sec0005}
===========================================================

Membrane fusion, i.e., the merging of two initially separate and apposed lipid bilayers with the result of the mixing of two initially distinct aqueous compartments, is ubiquitous to cell life. This unfavorable event typically advances at the expense of protein refolding energy, and under the control of mechanisms that ensure its evolvement at defined cell locations and physiological stages. Despite the variety of physiological conditions involving membrane fusion events, the same basic principles underlying lipid bilayer remodeling seem to apply to all the expressions of this phenomenon (see [@bib0130], [@bib0135], [@bib0225], [@bib0405], [@bib0950]) and references therein for comprehensive reviews on this issue).

The protein-assisted membrane fusion reaction has been co-opted by lipid-enveloped pathogens, including enveloped viruses ([@bib0895], [@bib0900]). Thus, enveloped viruses comprising highly relevant human pathogens such as Influenza virus (IFV), human immunodeficiency virus (HIV) or Ebola virus (EBOV), make use of membrane glycoproteins for selecting host cells, induce membrane fusion and gain access to internal compartments, a sequence of processes collectively known as "viral entry"([@bib0900]). Given the dynamic nature of viral genomes and the vast number of replication cycles taking place during infection of a single host, viral entry machineries are subject to intense molecular evolution. Thus, the themes of glycoprotein structure--function common to all enveloped viruses are highly significant for the understanding of the general mechanism of protein-mediated fusion ([@bib0070], [@bib0130], [@bib0135], [@bib0330], [@bib0345], [@bib0405], [@bib0455], [@bib0535]). In addition, the conserved elements of these machineries, transiently or permanently exposed on the virion surface, provide clinical targets for development of inhibitors (antivirals) and immunogens (vaccines) ([@bib0065], [@bib0145], [@bib0170], [@bib0210], [@bib0360], [@bib0570]).

[Fig. 1](#fig0005){ref-type="fig"}A displays a generally accepted mechanism of membrane fusion induced by prototypical Class I viral glycoproteins, such as those of IFV, HIV or EBOV. The model is supported by the available structural and functional evidence (reviewed in references [@bib0070], [@bib0170], [@bib0330], [@bib0535], [@bib0780], [@bib0915]). The mature envelope glycoproteins in those viruses are organized as trimers of non-covalently associated heterodimers. Each heterodimer is composed of a surface and a trans-membrane subunit, which mediate receptor binding and virus-cell fusion, respectively ([@bib0385], [@bib0700], [@bib0780], [@bib0915]). Upon fusion activation, the ectodomain of the membrane-anchored subunit undergoes a series of conformational changes conducive to membrane merger. First a "pre-hairpin" intermediate forms to anchor viral and cell membranes through the transmembrane (TMD) and fusion peptide (FP) domains, respectively. The presence of the FP within the ectodomain exposed to the aqueous phase constitutes a feature shared by all viral fusion proteins, and represents an absolute requirement for their fusogenic function (previously reviewed in: [@bib0160], [@bib0180], [@bib0585], [@bib0830]). These hydrophobic and conserved sequences usually located at the N-terminal end of the fusogenic subunit, or close to it ([Table 1](#tbl0005){ref-type="table"} ), are thought to be involved in driving the initial partitioning of the fusion protein into the target membrane ([@bib0595]). In this first stage, formation (IFV hemagglutinin (HA)) or completion (HIV-Envelope protein (Env)) of an extended coiled coil (red rods in [Fig. 1](#fig0005){ref-type="fig"}A) by N-terminal helices (or N-terminal heptad repeats, NHRs) would be the propelling force that brings about exposition and translocation of the initially cryptic FP into close vicinity of the target membrane.Fig. 1Viral glycoprotein-induced membrane fusion and proposed functions for the FP in the process. (A) General model of membrane fusion promoted by Class I viral fusion glycoproteins. (B) Stages of the process from a lipid-centric perspective (see text). (C) Putative effects of FPs on target membrane rupture and deformation during fusion (see text).Table 1VFPs of Class I fusion proteins.FamilySpecies[a](#tblfn0005){ref-type="table-fn"}Sequence[a](#tblfn0005){ref-type="table-fn"}PositionFYW[b](#tblfn0010){ref-type="table-fn"}*ΔG* Interfacial[c](#tblfn0015){ref-type="table-fn"}Ala Percent[d](#tblfn0020){ref-type="table-fn"}Gly Percent[d](#tblfn0020){ref-type="table-fn"}RetroviridaeHTLV-1AVPVAVWLVSALAMGAGVAGGITGSN-terYes--1.2424/920/8HIV-1AVGIGALFLGFLGAAGSTMGARSN-terYes--2.2922/726/7ASLVGPTARIFASILAPGVAAAQALREIERLAInternalYes5.9429/87/7SIVGVFVLGFLGFLATAGSAMGAASN-terYes--3.8623/723/7BLVSPVAALTLGLALSVGLTGINVAVSN-terNo-0.5817/713/3FiloviridaeEBOVGAAIGLAWIPYFGPAAEInternalYes--1.329/518/6MARVLAAGLSWIPFFGPGIInternalYes-4.4513/520/7CoronaviridaeSARS-CoVMYKTPTLKYFGGFNFSQILN-terYes--3.070/811/7GAALQIPFAMQMAYRFInternalYes--1.4225/86/7OrthomyxoviridaeIFV-AGLFGAIAGFIENGWEGMIDGWYGN-terYes--2.529/830/6ParamyxoviridaePIV5FAGVVIGLAALGVATAAQVTAAVALVN-terYes0.0435/1113/4NDVFIGAIIGSVALGVATAAQITAAN-terYes--0.4530/813/8HeVLAGVVMAGIAIGIATAAQITAGVN-terNo0.2730/617/6[^1][^2][^3][^4]

The filamentous structure of the "pre-hairpin" subsequently collapses into the low-energy trimeric "hairpin". In the trimeric hairpin structure, the ectodomain amino- and carboxy-termini are placed at the same end of the molecule ([@bib0170], [@bib0875]). In several instances, this second step might ensue due to the fact that the extended N-terminal coiled coil creates highly conserved grooves into which C-terminal helices (or C-terminal heptad repeats, CHRs) may hydrophobically pack in an antiparallel orientation (yellow rods in [Fig. 1](#fig0005){ref-type="fig"}A). It is assumed that the conformational energy released during the trimeric hairpin formation can be used to pull membranes together and induce their merger, while its completion upon full zippering of the CHR would stabilize an open state of the fusion pore and likely contribute to its expansion ([@bib0535]).

Hence, insertion of the hydrophobic FP into the target membrane and formation of the low-energy 6-HB structure are common themes to all fusogenic Class I glycoproteins, which otherwise may vary in receptor specificity, size, sequence and activation pathways ([@bib0535], [@bib0900]). A great deal of experimental work produced in the course of the last 25 years supports this view. In one hand, convincing evidence for the insertion of the VFPs into target membranes was early provided by Brunner\'s group using hydrophobic photolabeling approaches ([@bib0165], [@bib0340], [@bib0855], [@bib0870]). The IFV glycoprotein HA is synthesized as a single polypeptide, which is posttranslationally cleaved into two disulfide-linked chains, HA1 and HA2. The hydrophobic N terminus of HA2 generated after cleavage embodies the IFV-FP. Brunner and co-workers demonstrated that, upon incubation at conditions that activate IFV fusion (i.e., pH 5.0 and 37 °C), the hydrophobic interactions of isolated BHA2 (the bromelain-solubilized form of hemagglutinin) or IFV virions were mediated solely by the N-terminal segment of the HA2 subunit, which corresponds to the FP ([@bib0340], [@bib0855]). They found that the predominant sites of labeling within this segment were spaced in average 3--4-residues, thereby suggesting that the FP inserted into the target membrane adopting a helical structure with an amphiphilic character (see also [Fig. 3](#fig0015){ref-type="fig"}B below). From asymmetric hydrophobic photolabeling of membranes, evidence was obtained indicating that HA2-FP penetrates only the external leaflet of the bilayer in the fusion pH conformation ([@bib0080]). In addition these authors provided evidence to sustain a mechanism of IFV inactivation at acidic pH, according to which the HA2 FP irreversibly inserted into the viral membrane ([@bib0870]).

On the other hand, crystallographic evidence for the formation of low-energy trimeric hairpins by divergent virus glycoproteins has been accumulated during the last two decades ([@bib0170], [@bib0330], [@bib0875], [@bib0900], [@bib0945]). The fact that Class II glycoproteins make use of trimeric hairpins to induce fusion underpins the functional relevance of these structures ([@bib0330], [@bib0860]). However, in contrast to the helical domains implied in Class I fusion, the Class II glycoprotein subunits employ articulated β-barrel domains to assemble membrane-pulling trimeric hairpins ([@bib0330], [@bib0860], [@bib0900]). Yet another class of fusion glycoproteins combine structural features of Class I and Class II fusion proteins, and have been designated as Class III ([@bib0040], [@bib0045], [@bib0880], [@bib0900]). Fusogenic subunits of Class II and Class III proteins possess conserved hydrophobic loops that connect extended strands at the tip of elongated β-barrel domains. These "fusion loops" (FLs) are thought to insert into the target membrane and function during fusion in a way reminiscent of Class I FPs. Thus, the fact that Class I/II/III glycoproteins make use of similar elements, but different structural scaffolds, highlights the functional convergence underlying cell-virus membrane fusion.

Structure--function relationships of VFPs derived from diverse viruses with relevance as human pathogens, such as IFV ([@bib0315], [@bib0440], [@bib0680]), HIV-1 ([@bib0010], [@bib0400], [@bib0465], [@bib0555], [@bib0590], [@bib0650], [@bib0675], [@bib0745], [@bib0765], [@bib0930]), and EBOV ([@bib0705]) have been extensively studied in the course of the last decades. We previously reviewed many aspects of VFP-membrane interactions, paying particular attention to the physiological relevance of studies based on synthetic peptides and membrane models ([@bib0585]). For excellent, contemporary reviews on VFP-related issues the reader is referred to: ([@bib0160], [@bib0180], [@bib0190], [@bib0620], [@bib0825]). Here, we first give a brief overview on our current understanding of the structure and function of the VFPs, and then update some case studies (Sections [2](#sec0010){ref-type="sec"}, [3](#sec0035){ref-type="sec"}, respectively). This review primarily focuses on Class I VFPs, as they conform more closely to the notion of FP domain ([@bib0190], [@bib0250]). Nonetheless, Section [4](#sec0060){ref-type="sec"} will be devoted to the description of Class II/III FLs. Section [5](#sec0065){ref-type="sec"} will deal with the possible assistance by other hydrophobic-conserved regions present in glycoprotein sequences, particularly the "membrane-proximal external regions" known as MPER domains. Finally in Section [6](#sec0070){ref-type="sec"}, based on the HIV-1 case, we will succinctly discuss the potential implications of this knowledge for the development of unprecedented anti-viral compounds.

2. Structure--function analyses of VFPs {#sec0010}
=======================================

2.1. Primary structure {#sec0015}
----------------------

[Table 1](#tbl0005){ref-type="table"} summarizes information relative to the primary structures of VFPs derived from most prominent Class I enveloped viruses. One feature shared by these sequences is that, despite the phylogenetic divergence, amino acid homology between FPs from Class I viral families can be as high as 90% ([@bib0250]). VFPs also gather unusual amounts of Ala and Gly residues, and, in particular when located internally, they contain invariable Pro residues ([@bib0280]). Such a degree of residue conservation and Ala/Gly content are uncommon for hydrophobic protein domains as signal sequences or transmembrane anchors. The occurrence of these residues further suggests an intrinsic conformational flexibility that cannot be explained by the simple requirement of membrane insertion. Thus, FP sequences have evolved constrained by selective pressures beyond the thresholds imposed by mere hydrophobicity or amphipathicity.

Aromatic residues are also present in VFP sequences, although exceptions to this rule may be found ([Table 1](#tbl0005){ref-type="table"}). These residues may help overcome the energy cost of peptide bond partitioning into membranes, particularly when this cost cannot be counterbalanced by the adoption of a defined secondary structure ([@bib0595], [@bib0905]). In this regard, aromatics' contribution maybe relevant for enabling membrane insertion of internal FPs ([Table 1](#tbl0005){ref-type="table"}). In these instances, the absence of a free N-terminus constraints conformational transitions in contact with the membrane surface ([@bib0280], [@bib0800]). The favorable interactions of aromatic side chains with phospholipid moieties located at the membrane interface region may in addition contribute to stabilize the insertion of the FP sequence into just one bilayer leaflet ([@bib0905]). An initial interaction restricted to one monolayer has been proposed to generate elastic stresses conducive to bilayer fusion (see below).

2.2. Native structures of VFPs {#sec0020}
------------------------------

The most stringent constraint imposed onto VFP sequences is probably the requirement of folding after synthesis as a constituent of the glycoprotein\'s globular ectodomain. This would represent the first stage in the life of VFPs ([Fig. 1](#fig0005){ref-type="fig"}A-(1)). The IFV-FP solved within the trimeric HA complex was for many years the only available VFP atomic structure in a native, pre-fusion state ([@bib0915]). The native IFV-FP folds as a loop partly buried into a pocket of ionizable residues, and with the hydrophobic N-terminus occluded at interfaces between HA2 transmembrane subunits. However, the IFV-FP model is not generalizable to all Class I viral fusion glycoproteins, as evidenced by the native structures available later on ([@bib0445], [@bib0515], [@bib0945]). Thus, EBOV-FP and Parainfluenza virus-5 (PIV5)-FP locate in the periphery of the pre-fusion glycoprotein complex, partially accessible from solution, and interacting extensively with the surface subunits ([@bib0445], [@bib0945]). A similar pattern has been recently suggested for the HIV-FP ([@bib0380], [@bib0515]). Thus, the occurrence of distinct native structures suggest that the VFP sequence homology between divergent virus families probably sustains common functional roles beyond folding after synthesis.

2.3. Active VFP structures and membrane destabilization {#sec0025}
-------------------------------------------------------

After fusion activation the VFPs must be exposed in the vicinity of the target membrane. Especially in the case of N-terminal sequences, it is assumed that membrane partitioning, initially driven by favorable hydrophobic interactions between FP monomers and the membrane interface ([Table 1](#tbl0005){ref-type="table"}), will result in the partitioning-coupled structuring of the FP sequence as an autonomous domain. Thus, structures adopted within the target membrane milieu might represent a second functional state common to all VFPs ([Fig. 1](#fig0005){ref-type="fig"}A-(2)). From that perspective, experimental approaches based on synthetic surrogates and model membranes have been applied to establish physiologically relevant, functional VFP states (see for earlier discussions on this issue [@bib0160], [@bib0190], [@bib0585]). Insertion patterns and conformations adopted by synthetic versions of the VFPs in model membranes and mimics have been characterized by a plethora of biophysical and structural techniques including Nuclear Magnetic Resonance (NMR) ([@bib0105], [@bib0315], [@bib0660]), Electron Paramagnetic Resonance (EPR) ([@bib0520], [@bib0835]), and Infrared spectroscopy (IR) ([@bib0090], [@bib0095], [@bib0200], [@bib0300], [@bib0325], [@bib0465], [@bib0510], [@bib0525], [@bib0555], [@bib0630], [@bib0625]). These studies reveal that the main conformation adopted by VFPs in membranes, insertion depth and insertion angle may vary depending on factors like the membrane lipid composition (particularly the presence of cholesterol or anionic phospholipids) or peptide length ([@bib0400], [@bib0415], [@bib0885]). When physiologically relevant, as it is the case of single sequence substitutions that recreate mutations interfering with the fusogenic activity of the full glycoprotein, these factors allow delineating structure--function relationships shared by VFPs from distinct origin ([@bib0585]).

The IFV-FP sequence is probably the most widely studied VFP following this approach. The HA2 post-fusion structure reveals N- and C-terminal residues that form an N cap terminating both the N-terminal α-helix and the central coiled coil ([@bib0125]). This structure implies that continuous α helices are not required for membrane fusion at either the N or C termini of the trimeric hairpin. In addition, residue 34 marks the end of the capping structure at the N-terminus, thereby suggesting that the functional structures and dynamics in membranes of the upstream IFV-FP (residues 1--23) are likely to be barely affected by the rest of the HA2 sequence. A main helical structure adopted by a synthetic IFV-FP in contact with membranes and its mimics was put forward by early studies ([@bib0110], [@bib0155], [@bib0300], [@bib0440], [@bib0510]). Additional studies revealed that insertion of this element could lead to lipid bilayer destabilization as evidenced by the induction of leakage of aqueous contents and lipid-mixing when added to liposomes ([@bib0140], [@bib0200], [@bib0440], [@bib0680]). A further line of evidence suggested that an oblique angle of insertion into the lipid bilayer might be required to sustain those membrane destabilization phenomena ([@bib0200], [@bib0300], [@bib0510]).

The effects of replacing N-terminal glycine, which may cause hemifusion or abolish fusion activity in the full protein, were found to affect both the adopted structure and the capacity for destabilizing lipid vesicles by the IFV-FP (reviewed in: [@bib0585], see also next section). In one study, the main α-helical conformation was observed in all the analyzed variants ([@bib0300]). However, the nonfusogenic peptides exhibited larger amounts of β-like conformers. A later work related the absence of activity of the HA2 bearing the G1V mutation to a change in the angle of insertion of the helical FP into membranes as measured by polarized IR ([@bib0200]).

Similarly, the polar V2E substitution at the N-terminus of the HIV-FP was known to interfere with gp41-induced fusion ([@bib0585]). The V2E change impaired insertion of synthetic HIV-1-FP into membrane monolayers and caused a reduction of membrane activity measured in liposomes. However, in contrast to what is observed for IFV-FP, the HIV-FP may adopt a functional β-strand structure in contact with membranes ([@bib0090], [@bib0095], [@bib0415], [@bib0555], [@bib0730], [@bib0920]), and the V2E substitution was shown to interfere with the adoption of that conformation ([@bib0235], [@bib0630]). A series of Attenuated Total Reflectance (ATR)-IR studies also suggested an oblique angle of insertion for the membrane-bound functional HIV-FP ([@bib0525], [@bib0530]), which was confirmed by later structural determinations ([@bib0095], [@bib0565]). Thus, insertion in an oblique angle and the capability of alternating α/β conformations depending on membrane dose and lipid composition emerged as common structural patterns from those analyses. However, the membrane-bound conformation most active at generating membrane destabilization differed in the IFV-FP or HIV-FP.

The functional meaning of the conformational polymorphism of membrane-bound VFPs is yet unclear. Some authors argue that VFPs function as inert anchors, i.e., "secondary" transmembrane domains (TMDs) inserted into the target membrane ([@bib0150], [@bib0780]). According to this view, conformational polymorphism of the membrane-inserted FP might contribute to the flexibility of the fusogenic complex during the fusion reaction cycle ([@bib0745], [@bib0800]). Following the "hairpin" model ([Fig. 1](#fig0005){ref-type="fig"}A), the rod-shaped glycoprotein ectodomain must alternate a configuration with its axis perpendicular to the target bilayer normal (inserted prefusion state) with a configuration mainly parallel to the membrane interface supposedly adopted within the trimeric hairpin structure. Thus, the presence of jointed kinks to enable backbone reorientation and the capacity for alternating FP insertion levels might be required for the final stages of the fusion cascade to evolve.

An alternative option is that it is the membrane structure, rather than peptide\'s structure, what changes upon VFP insertion. Under this view, VFPs would be membrane-active agents, while the hairpins would behave as mechanical devices that bring into apposition membranes poised for fusion ([Fig. 1](#fig0005){ref-type="fig"}A). Accordingly, the functional link with conformational polymorphism has been established by combining peptide structural studies, membrane stability assays and determinations of changes in structure and material properties of the bilayer, both in liposome and bulk lipid systems ([@bib0140], [@bib0190], [@bib0195], [@bib0200], [@bib0320], [@bib0635], [@bib0775], [@bib0845]).

[Fig. 1](#fig0005){ref-type="fig"}B briefly describes the remodeling processes undergone by the lipid bilayer along the proposed fusion pathway ([@bib0130], [@bib0135], [@bib0405]). Bilayers must be first brought into close apposition, a process that requires overcoming the highly repulsive hydration and electrostatic forces operating at the membrane surface ([Fig. 1](#fig0005){ref-type="fig"}B-1). Repulsion can be minimized within pointlike membrane protrusions created by focal application of curvature/tension stress ([Fig. 1](#fig0005){ref-type="fig"}B-2-top). Formation of these structures might lead to closer apposition of the contacting monolayers and generation of small hydrophobic patches. The most widely accepted model, based on a continuous approach of membranes in terms of their elastic properties, posits that an hourglass-shaped lipid structure termed "stalk", with mean negative curvature, subsequently emerges at the point where interbilayer contact has been established ([Fig. 1](#fig0005){ref-type="fig"}B-2-bottom). The stalk allows mixing of the lipids from the contacting monolayers (*cis*-monolayers), but not of those from the distal ones (*trans*-monolayers). According to the original proposal of the stalk theory, distal monolayers collapse into a single bilayer referred to as a "hemifusion diaphragm" (HD) ([Fig. 1](#fig0005){ref-type="fig"}B-3-top). Increasing tension at the HD leads to the formation of a small hydrophilic pore, a process facilitated by positive curvature of the HD monolayers ([Fig. 1](#fig0005){ref-type="fig"}B-3-bottom). A "fusion pore" is eventually formed, which connects the internal aqueous volumes enclosed by the originally separated membranes ([Fig. 1](#fig0005){ref-type="fig"}B-4).

[Fig. 1](#fig0005){ref-type="fig"}C summarizes the VFP effects putatively related to the promotion of the membrane rupture and/or deformation processes along that pathway. In a first instance insertion into one monolayer of an amphipatic VFP structure might help overcoming the hydration repulsion force between approaching bilayers by orienting a poorly solvated face toward the external medium ([Fig. 1](#fig0005){ref-type="fig"}C (1)). Pre-stalk fusion intermediates maybe subsequently elicited by breaching lipid continuity and generating focal hydrophobic patches ([Fig. 1](#fig0005){ref-type="fig"}C (2)). Recent molecular dynamic simulations (MDS) suggest that hydrophobic defects generated by IFV-FP in the "boomerang" conformation (see below) might cause lipid tail protrusions ([@bib0430]). It has been argued that a lipid molecule splaying its two acyl chains may suffice to build an initial lipid bridge between contacting bilayers ([@bib0225], [@bib0390], [@bib0405]).

VFP-induced monolayer negative curvature may also minimize the stalk formation energy ([Fig. 1](#fig0005){ref-type="fig"}C (3)). Indirect proof consistent with this effect comes from the capacity of VFPs for lowering the temperatures of lamellar-to-non-lamellar (H~II~) phase transitions. Accordingly, the ability of HIV-1-FP to induce lipid mixing in large unilamellar liposomes was correlated with its ability for modulating the lipid polymorphism in bulk systems ([@bib0635]). This concept was also supported by studies addressing the effects of point mutations at the N-terminal amino acid, Gly, of IFV-FP ([@bib0195], [@bib0200]). Only the wild-type peptide could substantially decrease the temperature of the lamellar-to-non-lamellar (H~II~) phase transition at pH 5. In addition a correlation existed between the fusogenic activities of the full protein and the effect of the FPs on monolayer curvature, as monitored by a shift in the temperature of the polymorphic phase transition.

More recent theoretical developments stipulate that asymmetric insertion of hydrophobic protein domains into one membrane monolayer may promote expansion of the polar head region and impart curvature stress onto the overall lipid bilayer (reviewed in [@bib0405]). In the case of the HIV-FP, it was hypothesized that insertion into the external membrane monolayer may induce lateral stress in the hydrocarbon region and/or selectively induce an increment of its surface ([@bib0010]). As a consequence bulges (or dimples) that protrude from the membrane plane would be created ([Fig. 1](#fig0005){ref-type="fig"}C (4) right panel). The tops of these structures are highly curved, an arrangement that can facilitate the formation of lipid contacts between fusing bilayers ([@bib0405]). This mode of VFP action would be also consistent with an alternative mechanism of fusion, which posits that the process can be mediated by activated glycoproteins with their FPs inserted into the viral membrane ([@bib0130]). Bilayer deformation can be additionally facilitated by compounds that lower the bending rigidity of the bilayer. Thus membrane-embedded VFPs may behave as additives that disorder and soften the lipid bilayer matrix making it more prone for bending or expansion ([Fig. 1](#fig0005){ref-type="fig"}C (4) left panel). Recent low-angle x-ray scattering studies reveal that the inserted HIV-FP indeed reduces the bending modulus (*K* ~C~) of the lipid bilayer ([@bib0845], [@bib0850]).

Finally, VFPs may sustain the aperture of lipid fusion pores with distinctive architectures. In one hand, VFPs may promote the opening of hydrophilic pores within the expanding HD ([Fig. 1](#fig0005){ref-type="fig"}C (5)). Such mechanism would be supported by the finding that functional VFPs bear a pore-formation activity below the membrane rupture tensions ([@bib0435], [@bib0475], [@bib0470]), and by their capacity for inducing positive curvature put forward by recent MDS ([@bib0230]). However, it is difficult to envision how the FP attached to the glycoprotein ([Fig. 1](#fig0005){ref-type="fig"}A) would get access to the expanding HD, an element confined to a topologically distinct compartment.

On the other hand, under the assumption that the stalk does not expand, stalk formation and its evolution into a fusion pore are restrained by the energy of hydrophobic interstices (voids) emerging between contacting monolayers ([@bib0455], [@bib0770]). Thus, VFPs might contribute to lower the energy of those voids, thereby facilitating lipid mixing of *cis*-monolayers and/or establishment of *trans*-monolayer contacts (TMCs) ([Fig. 1](#fig0005){ref-type="fig"}C (6)). Evidence supporting this VFP role mainly derives from experiments of PEG-mediated fusion ([@bib0100], [@bib0320]). The physiological relevance of those studies has been put forward by the comparison of wild-type IFV-FP and two derived mutants, G1E and G13L. The wild-type peptide enhanced PEG-induced fusion, increased the bilayer interior packing and filled the membrane free volume, while the mutants caused no change in PEG-induced fusion or interior packing. It was inferred that the functional IFV-FP promotes conversion of the stalk to an expanded TMC intermediate through its ability to fill the voids within this latter structure ([Fig. 1](#fig0005){ref-type="fig"}C (6)).

In addition, the ability for minimizing interstice energy can be indirectly inferred from the effects on the thermotropic lamellar-to-non-lamellar (H~II~) phase transition. VFPs have been shown to drive the process toward the formation of bicontinuous inverted cubic phases (Q~II~) ([@bib0335]). Small-angle X-ray diffraction results showed that the action of the IFV-FP on lipid polymorphism was strongly pH-dependent ([@bib0140]). In particular, the ability of peptide to promote cubic phases exhibited the same dependence on the pH as viral fusion. Since bilayers arranged into bicontinuous Q~II~ phases bear curvatures reminiscent of those purportedly existing within unexpanded fusion pores, it has been proposed that a plausible mechanism of fusion-promotion by the IFV-FP could be that this element may help destabilizing bilayer diaphragms at TMCs, or favor bilayer states of negative Gaussian curvature ([@bib0775], [@bib0840]).

2.4. Membrane-inserted inactive VFP forms and fusion pore expansion {#sec0030}
-------------------------------------------------------------------

The neck in the early fusion pore structures can be sufficiently narrow as to impede diffusion of large solutes. Thus, driven by forces favoring membrane unbending, the final stage of the viral fusion process comprises the irreversible expansion of the initial fusion pore ([@bib0135]), a phenomenon required for the translocation of the macromolecular nucleocapsid complex into the cytosol of the host cell. Formation of the fully zipped trimer-of-hairpins ectodomain has been shown to be required for this step ([@bib0070], [@bib0535]). In turn, 6-HB completion may lead to the formation of complexes between the membrane-embedded N-terminal FP and the C-terminal TMD ([@bib0035], [@bib0820]). These integral membrane oligomers might represent the third and last stage in the life of the VFPs ([Fig. 1](#fig0005){ref-type="fig"}A-(3)). In contrast to forms inserted into single monolayers, FP-TMD transbilayer bundles would favor bilayers with 0 net curvature. Thus, membrane remodeling upon this locking movement might be coupled to fusion pore enlargement.

Although the participation of FP during the pre-hairpin intermediate state has been widely studied, only a few studies have focused on its possible co-assembly with TMDs and the involvement of the process in the late stages of fusion. Since FP and TMD domains lie in close proximity in the final trimeric hairpin structure of IFV-HA ([@bib0125]), and being this final conformation necessary to induce pore enlargement, Cohen and co-workers proposed that both domains approach each other to their maximum extent during the late stages of fusion ([@bib0075], [@bib0135]).

Following this idea, Chang et al. explored the existence of actual interactions between HA FP and TMD and its involvement in the IFV fusion process ([@bib0115]). They used fluorescently labeled peptides and model membranes, to assay formation of complexes between FP and TMD domains. The assembly occurred in an antiparallel manner, the TMD being at the core of the structure. In addition, as compared to homo-oligomers, the hetero-oligomers showed an enhanced membrane disrupting ability, likely due to a deeper membrane penetration of the FPs. These authors concluded that the assembly of the FP-TMD structure and its recruitment to the fusion site could cause the rupture of the membrane inner leaflets in a post-stalk state, resulting in initiation and enlargement of the fusion pore.

In a later contribution, Donald et al. addressed the existence of FP-TMD interactions in the case of the Class I fusion protein F of PIV5 ([@bib0150]). These authors observed that homo-oligomerization of isolated PIV5 FPs into hexameric bundles occurred in DPC micelles. According to ATR-IR results, FPs would adopt a transmembrane orientation in lipid bilayers. Supporting this idea, MDS of the FP six-helix bundle in lipid bilayers predicted a parallel orientation of the constituent monomers, with its periodically conserved small residues localized at the helix-helix interfaces, and allowing permeation of water into the hexamer core. Tight hetero-association of FP with TMD peptides also occurred in the membrane mimetic DPC. Based on their experimental data and the outcome of the simulations, the authors proposed that FP hexamers may create holes ("pinpricks") within the target membrane. Further tilting of the helices within approaching bilayers enable the formation of FP-TMD bundles, which eventually provides a low-energy pathway to direct fusion.

Finally, a more recent study of Reuven et al. has shown that the HIV-1 gp41 FP may also functionally associate with the C-terminal TMD ([@bib0685]). These authors made use of an in vivo fluorescence assay to determine FP hetero-assembly with the TMD (probably via its GLRI motif) within the membrane milieu, and the ability of the latter to self-assemble via its GxxxG motif. Besides, heteroassociation between FP and TMD peptides led to enhanced lipid mixing of model membranes. Furthermore, peptides derived from the TMD and FP could inhibit virus-cell fusion probably by interfering with the functional association of the parental endogenous regions. In conjunction these studies suggest that conserved Gly-Ala residues at regularly spaced intervals might sustain VFP homo- and hetero-oligomerization in membranes.

3. Updated case studies {#sec0035}
=======================

3.1. Influenza HA {#sec0040}
-----------------

Combining NMR-solved structures in micelles with EPR distance constraints measured in LUV, Tamm and co-workers proposed an "inverted V" or "boomerang" conformation for the functional IFV-FP in membranes ([@bib0315]). As compared to the neutral pH structure, the low pH structure of a 20-mer synthetic peptide inserts deeper while the C-terminal arm transitions from an extended structure to a shorter 3~10~-helix ([Fig. 2](#fig0010){ref-type="fig"} B-left). This low-pH-induced structural change was proposed to intensify the FP capacity to distort bilayer architecture (see also ([@bib0430])). The "inverted V" model was subsequently tested by assessing the effects of IFV-FP mutations that interfere with fusion activity of the full HA protein. In particular, the effects of G1S and G1V mutations, which respectively cause hemifusion and abolish fusion, were first examined ([@bib0460]). The NMR structures disclosed a V with a disrupted "glycine edge" on its N-terminal arm and a slightly tilted linear helical structure, for the G1S and G1V mutants, repectively. Abolishment of the kink in G1V resulted in reduced hydrophobic penetration of the lipid bilayer and an increased propensity to form β-structures at the membrane surface ([Fig. 2](#fig0010){ref-type="fig"}B-left).Fig. 2Native and membrane-inserted structures of IFV and EBOV fusion peptides. (A) X-ray structures disclosing several turns in the native fusogenic subunits. Structures on top disclose their position within the ectodomain. (B) NMR structures of peptides in DPC micelles reflecting features of α-helix. In both panels the orange stretches mark the positions of Gly/Pro residues. Structures with the PDB codes in brackets have been used to render the Figure.

The preservation of the low pH-induced, double-arm, "inverted V" structure as a requirement for IFV-FP function was further supported by the outcome of MDS in detergent micelles and lipid bilayers ([@bib0410]), and a series of structure--function studies ([@bib0420], [@bib0425]). The role of a specific fixed angle "boomerang" structure in fusion was underpinned by the effect of changing W14, a residue involved in kink stabilization ([@bib0420]). The W14A substitution was shown to cause inactivation of HA, while the structure of a synthetic IFV-FP bearing the mutation disclosed a flexible kink with an inverted orientation. Thus, the mutant pointed out of the membrane, in contrast to the ordered boomerang of the wild-type, which pointed into the membrane. The W14A fusion phenotype and FP structures were later reproduced by a double substitution F9A/I10A, an observation that underscores the functional importance of membrane-oriented large hydrophobic residues on both sides of the kink region of IFV-FP to fix the angle of the boomerang structure ([@bib0425]). Recently published MDS analyses give further support to this idea ([@bib0450]).

The importance of selecting FP sequence boundaries in structural studies was emphasized by the findings reported by Lorieau et al. ([@bib0480]). These authors included the conserved residues Trp21-Tyr22-Gly23 at the C-terminus of the IFV-FP, and analyzed the NMR structure in DPC micelles of the resulting specimen, which was designated as HA-FP^1--23^. The NMR structure of HA-FP^1--23^ dissolved in DPC disclosed an α-helix-turn-α-helix motif where N- and C-terminal helices packed tightly together in anti-parallel fashion ([Fig. 3](#fig0015){ref-type="fig"} A). Interactions between C-terminally added Trp21-Tyr22-Gly23 and the N-terminal residues of HA-FP^1--23^ were fundamental in the stabilization of this hairpin-like structure. The tight packing was in addition sustained by four interhelical aliphatic H-bonds. The hairpin was predominantly maintained even when lowering the pH below the pKa value of its acidic side chains. A charge--dipole interaction between the positive charge of the Gly1 α-amino group and the dipole moment of the second helix was subsequently described as an additional stabilizing force ([@bib0485]).Fig. 3Helical hairpin model for IFV-FP. (A) NMR structure of the synthetic HA-FP^1--23^ peptide in DPC micelles (PDB entry code: [2KXA](pdb:2KXA){#intr0005}). Side-chains of hydrophobic residues are displayed in green, while orange stretches in the ribbon mark positions of Gly residues. (B) Residue labeling in the sequence covered by HA-FP^1--23^ upon hydrophobic photolabeling of BHA incubated at low-pH in the presence of membranes. Percentages of label in the residues were calculated based on the data reported by ([@bib0340]). Side-chains of residues in green characters are depicted in the previous panel.

As shown in [Fig. 3](#fig0015){ref-type="fig"}A, the HA-FP^1--23^ hairpin segregates into one surface of the structure the hydrophobic residues Phe-3, Ile-6, Phe-9, Trp-14, Met-17, Trp-21 and Tyr-22. Interestingly, early assays performed by Brunner and coworkers ([@bib0340]) had identified in the radioactivity profiles these same residues (i.e., including Trp-21 and, to a lower extent, Tyr-22) as the main sites of labeling by membrane-residing photoactivable probes after low pH-induced interaction of BHA with liposomes ([Fig. 3](#fig0015){ref-type="fig"}B). This arrangement of the hydrophobic and hydrophilic residues relative to the hairpin surface generates an amphipatic structure predicted to stably associate with the water-lipid interface of a membrane leaflet. Thus, the hairpin structure would be also consistent with previous asymmetric hydrophobic photolabeling assays indicating that BHA-membrane interaction induced by low pH involves HA-FP insertion into the external membrane monolayer ([@bib0080]).

However, these authors later reported that at low pH, where the fusion process is triggered, HA-FP^1--23^ transiently visits activated states consisting of two stable helices switching between L-shape and extended arrangements, where the L-shape provides an intermediate step in the transition from the hairpin to a totally extended structure ([@bib0490]). They hypothesized that extension of the hairpin would elongate the IFV-FP to traverse the lipid bilayer, and therefore allow it assembling into bundles with C-terminal transmembrane helices (see preceding Section [2.4](#sec0030){ref-type="sec"}). Recent Solid State (SS)-NMR analyses confirm the adoption of closed hairpin structures in membranes by the 20-mer IFV-FP ([@bib0810]), although the fractional populations of hairpin and extended structures may be different in the lipid-bilayer context, as compared to micelles ([@bib0265]). In this regard SS-NMR results confirm the presence of "boomerang" structures in detergent micelles, but support the dominance of closed and semi-closed structures for membrane-associated IFV-FP at pH 5.1.

Thus it appears that segmentation into two helical arms joined by a kink, and fixation of the angle between both arms depending on sequence, pH and lipid environment, may encompass functional requirements for IFV-FP activity along the fusion pathway. It is possible that favorable IFV-FP insertion is driven by the compact hairpin structure, while subsequent target membrane destabilization would be promoted by its expanded structures. As mentioned above, a recent MDS study suggests that the "boomerang" structure might be involved in pre-stalk stages of the fusion process ([@bib0430]).

3.2. HIV-1 gp41 {#sec0045}
---------------

Similarly to the IFV-FP, high-resolution studies carried out in the course of the last decade reiterate the existence of conformationally polymorphic HIV-FP structures ([Fig. 4](#fig0020){ref-type="fig"} ), which are likely required to sustain the processes of folding into the globular ectodomain ([@bib0380], [@bib0515]), complex formation with inhibitors ([@bib0210], [@bib0570]) or adoption of alternating structures in a membrane milieu ([@bib0290], [@bib0285], [@bib0370], [@bib0465], [@bib0665]). In addition, MDS studies have provided supporting evidence for this idea ([@bib0050], [@bib0295], [@bib0655]).Fig. 4Conformational plasticity of HIV-FP. (A) Gallery of structures of synthetic peptides solved by IR ([@bib0290], [@bib0285]) and NMR ([@bib0370], [@bib0465], [@bib0570]). Corresponding PDB entry codes are displayed in red. [2JNR](pdb:2JNR){#intr0010} corresponds to the FP in complex with VIRIP (reddish chain). (B) Models for the FP inserted into Chol-containing membranes adopting 6-strand, anti-parallel β-sheet structures, as inferred from SS-NMR determinations. The most fusion-active version inserts deeper (see text). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)Source: Adapted from [@bib0665], © 2009 by National Academy of Sciences, USA.

However, these studies also confirm early observations indicating that membrane-active structures of IFV-FP and HIV-FP are different. After some debate at the time the proposal was first formulated ([@bib0555], [@bib0590], [@bib0630], [@bib0625]), considerable experimental evidence has been accumulated, which ascribes a fusogenic role to β-like extended HIV-FP structures ([@bib0090], [@bib0095], [@bib0325], [@bib0415], [@bib0710], [@bib0730], [@bib0745]). Most prominently, SS-NMR data reported by Weliky\'s group has provided in conjunction unambiguous evidence for the adoption of oligomeric β strand structure by the HIV-FP inserted into lipid bilayers ([@bib0660], [@bib0920], [@bib0935], [@bib0925]). In particular, the work by Qiang et al. was key to determine the relevance of this structure under fusion-promoting conditions ([@bib0665]) (see also [Fig. 4](#fig0020){ref-type="fig"}B). In that work the authors compared structure, fusogenicity and insertion depth of wild-type HIV-FP, a V2E mutant and a cross-linked trimeric HIV-FP that emulates the putative oligomerization state of HIV gp41. All peptides adopted a β-sheet structure in membranes with physiologically relevant cholesterol content. However, in liposome fusion assays the V2E peptide was not active, while trimeric HIV-FP displayed higher potency than the monomeric peptide. The membrane locations as inferred from SS-NMR measurements indicated subtle insertion of the V2E mutant at the membrane surface, deeper insertion into a single membrane leaflet for the monomeric wt, and the deepest level of insertion for the trimeric HIV-FP, which contacted with the center of the membrane. Thus, for a fixed β-sheet secondary structure, a deeper level of insertion correlated with higher fusogenicity. As depicted in the model of [Fig. 4](#fig0020){ref-type="fig"}B, an intriguing possibility is that the deeply inserted, distorted β-sheets might induce both local dehydration and hydrophobic defects in the monolayer (shadowed areas), thereby increasing the probability of hydrophobic tail flipping upon membrane adhesion ([Fig. 1](#fig0005){ref-type="fig"}B-(2)).

Thus, attending to the data derived from IFV-FP and HIV-FP studies, it appears that, irrespective of the main conformation, the level of insertion is key for inducing membrane remodeling. This concept has been further elaborated by Lai et al. in a more recent contribution ([@bib0415]). These authors report structure--function experiments consistent with the fusogenicity of α- and β-structures adopted by the HIV-FP in Chol-depleted or Chol-containing membranes, respectively (see also the discussion by [@bib0185]). According to these authors, it is possible that fusion domains first assemble as β-sheets on membrane surfaces but later convert into α-helices to complete fusion.

In the last years, particular attention has been also paid to the effect of additional gp41 sequences on the structure and fusogenicity of HIV-FP. In a series of works initiated by Sackett and Shai ([@bib0725]), the structure--function of the FP within constructs encompassing this region plus downstream gp41 helical domains has been investigated ([@bib0715], [@bib0710], [@bib0730], [@bib0735]). The early studies in this series demonstrated that in trimeric constructs containing the NHR oligomerization domain to model the pre-hairpin intermediate, the FP sequence remained active while retaining its tendency to assemble into β-sheet structures in the membrane ([@bib0725], [@bib0730]). Later analyses have revealed that fusogenicity of the FP is hampered within a construct representing post-fusion 6-HB structures, even though the membrane-associated extended structure still existed within these constructs ([@bib0710], [@bib0715]). In conjunction, these data underscore the fusogenic function of the FP sequence during the fusion stages that precede trimeric hairpin formation, and support the hypothesis that the FP of HIV constitutes an autonomous folding domain.

3.3. Paramyxovirus F protein {#sec0050}
----------------------------

The native structure of the PIV5-FP combines features of β-sheet and α-helical conformations ([@bib0945]). The C-terminal helix of the FP extends into the F protein N-terminal helical domain, and the joint connecting both domains likely remains helical upon fusion activation. Thus, in contrast to IFV-FP, the post-fusion PIV5-FP would extend the N-terminal helix into the membrane to enable its assembly with the TMD into an integral 6-helix bundle ([@bib0150]). Consistent with the functional role of the α-helical conformation, Gly substitutions in the FP exhibited increase in fusion activity in transfected cells ([@bib0350]), and augmented the helical content of the cognate synthetic peptide ([@bib0610]).

Some structure--function studies combining synthetic Paramyxovirus FPs and model membranes have been added in recent years to the works already consigned in our previous review ([@bib0585]). Smith and coworkers identified a double mutation VM114/115AA in Hendra F protein that blocked fusion activity ([@bib0790]). These authors subsequently examined changes in membrane interactions, using synthetic peptides representative of both wild-type and VM114/115AA mutant F proteins. Consistent with an alteration of the membrane interaction pattern, incubation with the VM114/115AA peptide resulted in a 75% reduction of hemolysis. Moreover, the wild-type peptide exhibited greater helical content as estimated from circular dichroism measurements. Together, these data support that the helical FP structure is important to drive efficient paramyxovirus membrane fusion.

In a more recent study Yao and Hong have analyzed the lipid interactions of the PIV5-FP by means of SS-NMR ([@bib0940]). These studies reveal a conformational polymorphism for PIV5-FP as a function of the composition of the phospholipid membrane in a way reminiscent of the HIV-FP. Thus, PIV5-FP was found to adopt α-helical structure in anionic membranes, but it was mostly β-sheet in neutral ones. The latter structure caused membrane surface dehydration and curvature. Accordingly the authors ascribe a role for the PIV5-FP β-sheet structure in promoting/stabilizing the hemifusion intermediate. In contrast, the α-helical state would be associated with the extended prehairpin state and the post-fusion state ([@bib0150]).

3.4. Ebola GP {#sec0055}
-------------

The crystal structure of the EBOV-FP was solved in the trimeric, pre-fusion conformation of the envelope glycoprotein (GP) ([@bib0445]). In contrast to the previously reported IFV-FP or PIV5-FP structures, the EBOV-FP embodied an internal fusion loop lacking a free N terminus ([Fig. 2](#fig0010){ref-type="fig"}A-right and [Table 1](#tbl0005){ref-type="table"}). The hydrophobic EBOV-FP was displayed onto an antiparallel β-stranded scaffold, which was stabilized by a disulphide bond at the base. However, similarly to PIV5-FP, the side chains of the most hydrophobic residues at the tip of the EBOV-FP packed into a neighboring GP surface subunit in the trimer, while the rest of the sequence sat in the periphery of the complex, partly accessible from solution.

Prior to the X-ray structure resolution of the native structure, several studies addressed the interactions of the internal EBOV-FP with membranes. These initial reports suggested that anionic phospholipids might be required for the efficient insertion of EBOV-FP into membranes ([@bib0705], [@bib0800]). This requirement was not based on the establishment of strong peptide-lipid electrostatic interactions, but rather on the easier access of the FP sequence to the hydrophobic region in the anionic bilayers, and the favorable contribution of its partial structuring therein to the overall energy of partitioning. A helix inserted in a tilted orientation was subsequently posited as the effective fusogenic structure of the sequence ([@bib0005]). Somehow contrasting this proposal, it was further suggested that stabilization of a loop structure within membranes by a Pro residue was required for the EBOV-FP membrane activity ([@bib0280]).

Both possibilities need not be mutually exclusive as put forward by later high-resolution NMR studies ([@bib0220], [@bib0305]) ([Fig. 2](#fig0010){ref-type="fig"}B-right). In accordance with previous low-resolution studies, the EBOV-FP sequence was shown to get partially structured in contact with SDS micelles at pH 7.0 by adopting a 3~10~-helix in the central part ([@bib0220]). Furthermore, spectroscopic measurements and MDS suggested the participation of the central aromatic residues in interactions with rigid membranes (see also ([@bib0215])). Gregory and co-workers further analyzed the effect of the β-sheet scaffold and pH on the structure adopted by EBOV-FP in membrane mimics ([@bib0305]). Their analysis yielded a model for the structure--function of this domain ([Fig. 2](#fig0010){ref-type="fig"}B-right). According to these authors, a conformational change from a relatively flat extended loop structure at pH 7.0 to a bent structure at pH 5.5 would reorient the hydrophobic patch at the tip of the FP. The latter structure display helical features within a reversing turn inserting into the membrane. It is tempting to speculate that the energy contribution from structuring one portion of the Cα chain is required for the favorable insertion of the full loop. This mode of interaction would facilitate disruption of lipids in a way reminiscent to that of N-terminal VFPs.

4. Fusion loops in Class II and Class III glycoproteins {#sec0060}
=======================================================

Based on sequence similarities, it has been proposed that Class II/III FLs and internal Class I FPs share functional and structural features ([Table 2](#tbl0010){ref-type="table"} ). However, the available experimental evidence is not fully compatible with that assumption. In one hand, some of the crystallographically solved Class II glycoproteins allow inferring the structure adopted by FL-containing regions in pre-fusion, fusion-activated and post-fusion states ([@bib0045], [@bib0270], [@bib0395]). All those structures reveal that the exposed hydrophobic FLs at the tip of elongated β-barrel domains (DII-s) are usually shorter than the predicted sequences ([Table 2](#tbl0010){ref-type="table"}). Aliphatic, aromatic as well as Gly residues are commonly found in β-strands, which, together with the unusual length of those elements in DII domains, obscured initial Class II/III FP detection based on sequence length and hydrophobicity distribution ([@bib0595]).Table 2VFPs of Class II and III fusion proteins.ClassFamilySpecies[a](#tblfn0025){ref-type="table-fn"}Sequence[a](#tblfn0025){ref-type="table-fn"}PositionPrefusion State*ΔG* Interfacial[b](#tblfn0030){ref-type="table-fn"}Ala Percent[c](#tblfn0035){ref-type="table-fn"}Gly Percent[c](#tblfn0035){ref-type="table-fn"}Class IIFlaviviridaeTBEVDRGWHNGCGLFGKGSIInternalHomodimer0.50/831/9DENV-1DRGWGNGCGLFGKGSLInternalHomodimer--0.70/738/10TogaviridaeSFVVYTGVYPFMWGGAYCFCDSInternalHeterodimer--3.864/813/7CHIKVVYPFMWGGAYCFCDTENTInternalHeterodimer--2.116/1112/6Class IIIRhabdoviridaeVSVWY/YABipartiteTrimeric--3.5625/50/7HerpesviridaeHSVVWFGHRY/RVEAFHRYBipartiteTrimeric0.77/117/7BaculoviridaeAcMNPVYAYNGGSLDPNTRV/VKRQNNNHFAHHTCNKBipartiteTrimeric8.367/57/5[^5][^6][^7]

On the other hand, the FLs adopt almost invariable conformations in pre- and post-fusion states ([Fig. 5](#fig0025){ref-type="fig"} ). This is because the globular structures of the FL-containing DII-s behave as rigid bodies along the fusion pathway, i.e., they do not undergo significant structural rearrangements during the process besides their spatial reorientation. It is thus inferred that, in contrast to Class I internal FPs, short Class II FLs would retain their short-loop conformation upon insertion into the target membrane, an assumption supported by structural studies based on synthetic sequences ([@bib0540], [@bib0545], [@bib0560]).Fig. 5Fusion loops derived from Class II and Class III glycoproteins. X-ray structures of FLs in pre- and post-fusion states of Class II DENV-E and Class III VSV-G glycoproteins are displayed (top and bottom panels, respectively). In both panels the exposed side-chains of aromatic residues are shown in green, while orange stretches mark the positions of Gly/Pro residues. Structures with the PDB codes in brackets have been used to render the figure.

The interaction involving just few hydrophobic residues, and the absence of autonomous folding within the membrane milieu suggest a subtle FL insertion into the outer leaflet of the membrane, which is likely insufficient to compromise the lipid bilayer architecture. This notion is further substantiated by the findings reported in the case of the Class III VSV-G protein ([@bib0690]). VSV-G contains at the tip of domain IV a bipartite FL composed of 2 short loops, which together contribute just three aromatic residues to the interaction with the target membrane ([Fig. 5](#fig0025){ref-type="fig"} and [Table 2](#tbl0010){ref-type="table"}). The fact that they may remain inserted into the viral membrane in the pre-fusion state further emphasizes that insertion of those residues does not by itself destabilize membranes ([@bib0695]). This is in contrast to Class I IFV, which shows dramatic changes in envelope morphology, fused virions and disorganized HA spikes upon low-pH-induced FP insertion into the envelope ([@bib0205]).

Thus, a cooperative effect attained upon fusion activation has been invoked to explain the induction of target membrane deformations by Class II/III glycoproteins. In vitro assays based on synthetic peptides and liposomes suggest that the context of the trimer can be critical for DENV E FL-induced membrane destabilization ([@bib0605]). Moreover, contacts between FLs inserted into the target membrane have been shown to render rings made of several SFV E1 trimers ([@bib0270]). The particular architecture of those rings would generate nipples within the target membrane, reminiscent of pre-stalk fusion intermediates.

5. Other glycoprotein hydrophobic regions: MPER domains {#sec0065}
=======================================================

Besides the canonical VFPs and VFLs discussed above, other regions within viral fusion proteins have been proposed to participate in fusion (reviewed in [@bib0620]). Among these regions, the NHRs of Class I glycoproteins were found to interact with membranes and postulated to cooperate in FP-induced fusion. This finding applied to several glycoproteins including influenza HA2 ([@bib0175]), Sendai virus F1 ([@bib0260]) and HIV-1 gp41 ([@bib0720]). In this latter case, substitution of the NHR by the coiled-coil promoting GCN4 sequence, rendered a less fusogenic construct (although still more active than the 33-mer FP) indicating that not only the coiled-coil conformation but also the sequence of NHR is essential for an increased fusion efficiency ([@bib0890]).

The presence of additional sequences featuring homology to the canonical FPs was found within the Sendai F1 ([@bib0615]), Measles F1 ([@bib0760]) and SARS-CoV S2 ([@bib0310]) proteins. Based on their potential capacity for interacting with lipid bilayers multiple regions have been additionally identified within diverse fusion glycoproteins such as Hepatitis C virus E1 and E2 ([@bib0640]), Dengue E ([@bib0580]) or Herpex Simplex virus gB and gH ([@bib0240], [@bib0245]).

All in all, this evidence suggests that the classical view of a single FP being solely responsible for the membrane interacting/perturbing activity of viral fusion proteins should be qualified by assuming a concerted action of different membrane-transferring regions. In support of this notion, the membrane proximal external region (MPER or preTM) that in Class I glycoproteins connects the CHR with the TMD, has been proposed to act as a C-terminal FP in several viral proteins ([@bib0505], [@bib0620]). A feature shared by MPER/preTM domains is the enrichment in aromatic residues, which are likely to enable their insertion into the viral membrane-interface ([@bib0795]). The presence of MPER domains has been extended to several Class I and II glycoproteins ([@bib0255], [@bib0505]).

Since its discovery a great deal of effort has been expended on dissecting the structure--function of the most paradigmatic MPER: the one derived from HIV-1 gp41. The first hint of the implication of this region in fusion was the discovery of the DP-178 peptide, now designated as T-20 (brand name: Fuzeon, generic name: enfuvirtide) ([@bib0910]). It was the first fusion inhibitor approved by the FDA in 2003 and the only currently approved drug targeting gp41. Its sequence (amino acids 643--678) overlaps partially that of the MPER (amino acids 662--683). Moreover, gp41-targeting antibodies that block HIV-1 entry into cells bind to epitopes within MPER ([@bib0505]).

Direct confirmation of MPER involvement on fusion was provided by mutagenesis studies reported a few years later ([@bib0575], [@bib0755]). Deletions, substitutions, and insertions in the MPER, abrogated the ability of HIV-1 Env to mediate both cell-cell fusion and virus entry, without affecting the normal maturation, transport, or CD4-binding ability of the protein. Interestingly, substitution of three of the five highly conserved tryptophan residues by alanines sufficed to block cell-cell fusion and virus entry ([@bib0755]). Further analysis of the W(1-5)A mutant revealed that fusion was abrogated at the non-expanding fusion pore stage ([@bib0575]). However, the precise mechanism by which this region participated in fusion was unclear.

Almost in parallel, Suarez et al. reported that a region spanning residues 664--683 showed high tendency to partition into the membrane interface, as revealed by the Wimley-White interfacial hydrophobicity scale ([@bib0795]). Confirming this prediction, a synthetic peptide representing this region bound, permeabilized and fused model membranes made of neutral phospholipids and cholesterol, even more potently than a peptide representing the FP. Moreover, replacement in this peptide of the first three Trp residues by Ala, reported by Salzwedel et al. to render a fusion defective gp41 phenotype, abrogated its ability to induce membrane fusion, supporting the physiological relevance of the in vitro approach ([@bib0795], [@bib0805]). Further development of the WW analysis suggested that MPER could be segmented into two segregated interfacial subdomains: C-terminal residues (673--683) are hydrophobic-at-interface and N-terminal residues (664--672) include a stretch whose face shows strong affinity for membranes if folded into an α-helix, i.e., an amphipathic-at-interface helix ([@bib0495], [@bib0740]). Supporting the functional relevance of this organization, a number of fusion-blocking deletions described by Salzwedel et al. correlated with the ablation and/or merging of interfacial sub-domains ([@bib0740], [@bib0755]). Later reported NMR structures confirmed the predicted MPER segmentation into two short helical subdomains ([@bib0815]).

To further establish a correlation between MPER insertion into and perturbation of the membrane and fusion, Vishwanathan and Hunter carried out a mutagenesis study ([@bib0865]) where MPER was replaced by the membrane-perturbing tryptophan-rich cationic peptide indolicidin, and revealed that some of the mutant Envs maintained fusogenic activity. This indicates that MPER insertion into membranes is not only a structure-related pattern, but also a requirement for the fulfillment of a membrane disrupting function during fusion. In addition, a number of studies employing model membranes and MPER-based synthetic peptides have shown that these membrane-perturbing activities are finely modulated by the lipid composition and the MPER segmentation into hydrophobic subdomains ([@bib0030], [@bib0025], [@bib0015], [@bib0020], [@bib0365], [@bib0750], [@bib0765], [@bib0805]). Taken together, these data point to a fusion model where MPER interfacial activity might help remodeling of the merging membranes along the fusion pathway by sustaining transient disruption of lipid continuity ([@bib0750], [@bib0765]) ([Fig. 1](#fig0005){ref-type="fig"}B-(2)). Alternatively, it has been suggested that MPER insertion might generate the bulging out of the viral membrane, while the curved end-caps of such bulges would be highly fusogenic ([@bib0085], [@bib0405]) ([Fig. 1](#fig0005){ref-type="fig"}B-(4)).

Finally, although high-resolution structures for the region are not yet available, an interesting possibility put forward by experimental evidence ([@bib0055], [@bib0495], [@bib0500]), is that both gp41 hydrophobic domains, MPER and FP, combine in the pre-fusion structure to render an overall soluble complex. The recently published SOSIP structure does not exclude such possibility ([@bib0380]). The fact that the FP stabilizes relevant structures of the MPER epitope targeted by the broadly neutralizing 2F5 antibody supports the interaction between both regions, and might as well have implications for the design of peptide immunogens ([@bib0355], [@bib0375]).

6. Prospects as therapeutic targets {#sec0070}
===================================

Self-oligomerization of membrane-embedded synthetic FPs has been claimed to reflect a physiologically meaningful phenomenon ([@bib0120], [@bib0400], [@bib0435], [@bib0925]). In the most amply studied case of the HIV, interference with formation of structurally defined oligomeric complexes was invoked to explain the inhibitory effect exerted by short synthetic FPs in cell systems ([@bib0400], [@bib0600], [@bib0645], [@bib0785]). Gomara and co-workers followed this idea to develop a functional screening assay ([@bib0275]). These authors took the advantage that in-membrane self-oligomerization of HIV-FP is required to establish permeating pores in vesicles made of anionic phospholipid ([@bib0590]). Thus, they used leakage of aqueous contents induced by the synthetic HIV-FP as a surrogate assay for self-oligomerization in membranes. Subsequently, a D-hexapeptide library was screened for its capacity to block FP-induced leakage (for a description of this assay see also ([@bib0360])). Using this approach two hexapeptides were identified that blocked gp41-induced fusion, thereby supporting the FP region as a potential target for inhibitor development.

Such statement was soon confirmed by the finding of VIRIP, the sole HIV-FP inhibitor tested so far in clinical studies ([@bib0210], [@bib0570]). Münch and coworkers purified an oligopeptide from hemofiltrate obtained from patients suffering from chronic renal failure, which was capable of blocking HIV-1 infection by targeting gp41 FP ([@bib0570]). This peptide, termed VIRIP (virus-inhibitory peptide), was later identified as a derivative from the C-terminal sequence of circulating serine protease inhibitor α1-antitrypsin. Optimized versions of VIRIP resulted as potent as T-20 in blocking viral infection and were devoid of cellular toxicity.

The VIRIP\'s molecular target was evidenced by its capacity for inhibiting synthetic FP-promoted hemolysis ([@bib0550]). VIRIP derivatives showing improved anti-HIV capacity were also more potent interfering with FP-induced hemolysis. Consistent with a direct FP-VIRIP interaction, structural determinations by NMR revealed the formation of HIV-FP/VIRIP complexes, in which both peptides bracketed together via hydrophobic interactions of the amino acid side chains ([Fig. 4](#fig0020){ref-type="fig"}A).

The outcome of a 10-day monotherapy clinical trial enrolling 18 HIV-1-infected patients was subsequently reported ([@bib0210]). The trial was meant to evaluate the safety, pharmacokinetics and antiviral efficacy of VIR-576, an optimized derivative of VIRIP. Treatment with VIR-576 was well tolerated by patients, and moderately reduced their plasma viral load. Together, VIRIP identification and its clinical evaluation, constituted a first proof of concept that FP inhibitors could suppress viral replication in infected individuals, and, therefore, support their clinical potential.

Finally, an intriguing possibility put forward by Shai\'s group is that the HIV-FP might bind the TMD of the T-cell receptor (TCR) α subunit, and interfere with the assembly of the TCR complex ([@bib0670]). Further MDS analyses supported the establishment of specific β-sheet/α-helix interactions between both sequences within the membrane ([@bib0060]). Thus, hetero-association with the TCRα TMD and ensuing immunosuppression may reflect that, behind the conventional membrane fusion, a hidden HIV-FP life might exist, also of relevance under pathological conditions.
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[^1]: HTLV-1: Human T-Cell Leukemia Virus Type 1, HIV-1: Human Immunodeficiency Virus Type 1, ASLV: Avian Sarcoma and Leucosis Virus, SIV: Simian Immunodeficiency Virus, BLV: Bovine Leukemia Virus, EBOV: Ebola Virus, MARV: Marburg Virus SARS-CoV: Severe Acute Respiratory Syndrome-Associated Coronavirus, IFV-A: Influenza A Virus, PIV5: Parainfluenza Virus 5 NDV: Newcastle Disease Virus and HeV: Hendra Virus.

[^2]: Presence of aromatic residues within the fusion peptide sequence.

[^3]: Computed according to the Wimley-White scale of water-membrane partitioning energies.

[^4]: Mole percent of alanine and glycine in fusion peptide over whole protein sequence.

[^5]: TEBV: Tick-Borne Encephalitis Virus, DENV-1: Dengue Virus type 1, SFV: Semliki Forest Virus, CHIKV: Chikungunya Virus, VSV: Vesicular Stomatitis Virus, HSV: Herpes Simplex Virus and AcMNPV: Autographa californica Multiple Nucleopolyhedrovirus.

[^6]: Computed according to the Wimley-White scale of water-membrane partitioning energies.

[^7]: Mole percent of alanine and glycine in fusion peptide over whole protein sequence.
